We are testing a personalized gene therapy for patients with advanced head and neck cancer. The goal is to see if it can improve treatment outcomes compared to standard options.
Health conditions and diseases that the clinical trial is designed to study and treat.
Head and Neck Squamous Cell Carcinoma (HNSCC) is a type of cancer that arises in the squamous cells lining the head and neck, often affecting areas like the oral cavity, oropharynx, hypopharynx, and larynx. It is commonly associated with HPV-negative cases and can be diagnosed at advanced stages (III or IV).
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
